BREAKING: Target Test Prep releases Brand New 2026 On Demand GMAT prep course

Redeem

Target Test Prep · GMAT

Choose how you want to prepare

Learn live with an expert or move at your own pace. Every option includes the complete TTP study system.

★★★★★5.0563 reviews
Newsweek Readers’ Choice Awards 2026 winner: Target Test Prep, #1 Test Prep
NEWSWEEK READERS’ CHOICE AWARDS 2026

Target Test Prep was voted #1 Best Test Prep in the 2026 Newsweek Readers’ Choice™ Awards.

GMATLiveTeach Starts Oct 17
Chris Peckover, Target Test Prep GMAT expert
LIVE ONLINE CLASSES

Get Ready for GMAT Test Day Faster with Live Online Classes

with Chris Peckover, 100th-Percentile GMAT Scorer

Oct 17 · Chris Peckover
Sat · 11:00 AM to 2:00 PM ET
Oct 20 · Chris Peckover
Tue, Thu · 8:00 to 10:00 PM ET
Oct 25 · Josh Braslow
Sun · 1:00 to 4:00 PM ET
Included
40 hours of live online classes + 6 months of TTP OnDemand
  • Attend the first class for free
  • Every class is recorded, so you never fall behind
View classes & enroll
Limited seats availableTarget Test Prep
EALiveTeachOnDemand 5 seats left Start anytime
EXECUTIVE ASSESSMENT

Target Test Prep EA OnDemand

Self-paced EA prep. Study on your schedule.

Logan Thompson
EXECUTIVE ASSESSMENT

Sep 6 to Dec 6, 2026

with Logan Thompson

165+ EA score guarantee
$05-day trial no automatic billing
Schedule
Sun · 9:30 AM to 12:30 PM ET
Included
40 hours of live online classes plus six months of access to the complete TTP EA OnDemand course.
  • 165+ EA Score Guarantee
  • 4,100+ Quant, Verbal, and Integrated Reasoning practice questions
  • 400+ hours of in-depth video lessons
  • 3,000+ step-by-step video solutions
View EA class & enroll Start free 5-day trial
Limited cohort · enrollment openTrial includes full course accessTarget Test Prep
GMATOnDemand Start anytime
SELF-PACED MASTERCLASS

Target Test Prep GMAT OnDemand

Complete access from day one. Study on your schedule.

715+ score guarantee
$0to start then $127/mo
  • Personalized study plan and analytics
  • Thousands of lessons and practice questions

Compare the format, schedule, and included access before enrolling. Prices and seat counts shown reflect the supplied offer details.

Prescription drugs-GPREP1

Expert replies
by medea66 » Wed Aug 20, 2008 8:05 pm
Is the expenditure referring to residents or drug manufacturers?
You do not have the required permissions to view the files attached to this post.
Join the discussion
Source: — Critical Reasoning |

by medea66 » Thu Aug 21, 2008 5:47 pm
please help!
Join the discussion

by kuroneko1313 » Fri Aug 22, 2008 10:46 am
I think it's A. The expenditure is referring to the resident in my opinion.
Join the discussion

by Suyog » Fri Aug 22, 2008 11:40 am
1. per capita expenditure on prescription drug increased by 15% or more anually.

2. ministry prohibited the manufacturers to increase the price. (price freeze)

Conclusion: still per capita expenditure on prescription drug increased.

2 says... population increased... but still if the population is increased.. they are buying the same drug... (constant price)
this doesnt prove that per capita expenditure on prescription drug increase by substantial %

but if manufacturers produce a new drug replacing existing drug then per capita expenditure on prescription drug will surely increase....
Join the discussion

by 4meonly » Sat Aug 23, 2008 1:11 am
Hope this will help:

By replacing old medications with new medication you can register high price from the beginning and not to increase it further. Also you can eliminate old medicines (they are usually cheaper) mking the whole treatment more costly
Join the discussion

by medea66 » Sat Aug 23, 2008 4:55 pm
So if the old medicine is replaced with new medicine, how is it possible to jack up the price on the new medication if there is a price freeze?
Join the discussion

by banker1 » Tue Aug 26, 2008 10:06 am
medea66 wrote:So if the old medicine is replaced with new medicine, how is it possible to jack up the price on the new medication if there is a price freeze?
The new medicine comes to market at a higher price to begin with. The manufacturer can stop producing the old medicine and force consumers to buy the new, more expensive medice.

HTH
Join the discussion

by jessica.ng1988 » Thu Sep 04, 2008 8:37 am
your choice weakens the argument rather than strengthen it.

in all choices,
only A support. A expresses that resident expenditure on drug still rise because of changed medication from drug manufacturers.
rest out of scope.
Join the discussion

by peter.p.81 » Wed May 11, 2016 2:24 am
Well I feel A is the answer. I guess I'm right. If some expert could
Join the discussion